A carregar...
Comparison of the efficacy and safety indicators of DMARDs for rheumatoid arthritis: A network meta-analysis
OBJECTIVE: To compare efficacy and safety indicators of disease-modifying antirheumatic drugs, Sarilumab, Sirukumab, Baricitinib, Tocilizumab and Adalimumab in rheumatoid arthritis treatment by a network meta-analysis. METHODS: Medline, Embase, Web of Science, The Food and Drug Administration web si...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8294891/ https://ncbi.nlm.nih.gov/pubmed/34398007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000026524 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|